drugset / Trial / NCT00293644

Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy

NCT00293644 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether pre-emptive use of a delayed release combination of pyridoxine hydrochloride and doxylamine succinate (Diclectin®), before eruption of symptoms of Nausea and vomiting of pregnancy and hyperemesis gravidarum, will reduce the incidence of severe forms of this syndrome/HG.

Timeline

Start
2006-02
Primary completion
2012-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclectin Unknown 20 mg —